Results 251 to 260 of about 167,650 (273)

A phase I study of the oral combination of CI-994, a putative histone deacetylase inhibitor, and capecitabine

Annals of Oncology, 2004
Thomas A Macek, Mark J Ratain, H L Kindler   +2 more
exaly  

Zinc binding groups for histone deacetylase inhibitors

Journal of Enzyme Inhibition and Medicinal Chemistry, 2018
Qixiao Jiang, Weiguo Song
exaly  

Histone deacetylase inhibitors in cancer therapy

Expert Opinion on Investigational Drugs, 2007
Ricky W Johnstone
exaly  

Environmental stimulation rescues maternal high fructose intake-impaired learning and memory in female offspring: Its correlation with redistribution of histone deacetylase 4.

Neurobiology of Learning and Memory, 2016
K. L. Wu, Chih-Wei J. Wu, Y. Tain, Li-Tung Huang, Y. Chao, Chun-Ying Hung, Jin-cheng Wu, Siang-Ru Chen, Pei-Chia Tsai, J. Chan   +9 more
semanticscholar   +1 more source

Histone deacetylase inhibitors: from target to clinical trials

Expert Opinion on Investigational Drugs, 2002
William Kelly, Paul Marks, Owen A O’Connor   +2 more
exaly  

Histone deacetylase (HDAC) 4 involvement in both Lewy and Marinesco bodies

Neuropathology and Applied Neurobiology, 2006
J, Takahashi-Fujigasaki, H, Fujigasaki
openaire   +2 more sources

Romidepsin: a novel histone deacetylase inhibitor for cancer

Expert Opinion on Investigational Drugs, 2011
Gregory A Otterson, Erin M Bertino
exaly  

Modifying histones to tame cancer: clinical development of sodium phenylbutyrate and other histone deacetylase inhibitors

Expert Opinion on Investigational Drugs, 2000
S D Gore, M A Carducci
exaly  

Targeting histone deacetylase in cancer therapy†

Medicinal Research Reviews, 2006
Chang-Shi Chen, HY Lin, Jing-Ru Weng
exaly  

Histone deacetylase-2 and airway disease.

Therapeutic Advances in Respiratory Disease, 2009
Peter J. Barnes
exaly